No Carolina / NY / Florida
Ph: 561.316.3330

ClearGuard HD Antimicrobial Barrier Caps Receive CE Mark Approval

Summation

  • The CE marking confirms that the ClearGuard HD cap meets the requirements of the European Medical Devices Directive, which now allows Pursuit Vascular to commercialize ClearGuard HD caps in the European Union and other CE Mark geographies.
  • Pursuit Vascular has seen rapid uptake of ClearGuard HD caps in the US following publication of landmark clinical studies demonstrating a ~70% reduction in bloodstream infections in patients using ClearGuard HD caps vs.
  •   “Pursuit Vascular is committed to creating technologies that aid in the prevention of catheter-related infection to enhance and extend the lives of patients around the world, and to reduce healthcare costs.

Pursuit Vascular, Inc., manufacturer of ClearGuard HD Antimicrobial Barrier Caps, today announced that the company has received both Conformité Européene (CE) Mark and Medical Device Single Audit Program (MDSAP) certificates for its ClearGuard HD caps, paving the way for launch in international markets.

The CE marking confirms that the ClearGuard HD cap meets the requirements of the European Medical Devices Directive, which now allows Pursuit Vascular to commercialize ClearGuard HD caps in the European Union and other CE Mark geographies.  The MDSAP certificate demonstrates compliance with regulations in Canada, Australia and Brazil.  The company is pursuing applications to market in these countries to facilitate launch of ClearGuard HD caps internationally later this year.

“The CE Mark and MDSAP approvals are significant accomplishments for Pursuit Vascular as it allows the company to expand sales to Europe and other key international markets,” said Doug Killion, President and CEO. “We look forward to working with hospitals and physicians in these countries to bring this lifesaving technology to more patients worldwide.”

Pursuit Vascular has seen rapid uptake of ClearGuard HD caps in the US following publication of landmark clinical studies demonstrating a ~70% reduction in bloodstream infections in patients using ClearGuard HD caps vs. patients using standard caps or needleless connectors.  The ClearGuard HD cap is the first and only device available for sale that kills infection-causing microorganisms inside a catheter hub between dialysis treatments.  Bloodstream infection is the second leading cause of death and a leading cause for hospitalization in hemodialysis patients, with catheters causing the majority of these infections.

“The extraordinary success of ClearGuard HD caps in the US clearly demonstrates that we’ve been able to provide a highly effective product that is rapidly becoming the standard of care for dialysis treatment,” continued Killion.  “Pursuit Vascular is committed to creating technologies that aid in the prevention of catheter-related infection to enhance and extend the lives of patients around the world, and to reduce healthcare costs.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img
spot_img
spot_img

Stay Connected

spot_img
spot_img

By using this website you agree to accept Medical Device News Magazine Privacy Policy